middle.news
How Will Zelira’s $1.07M R&D Refund Accelerate Its Clinical Pipeline?
2:51pm on Tuesday 25th of November, 2025 AEDT
•
Healthcare
Read Story
How Will Zelira’s $1.07M R&D Refund Accelerate Its Clinical Pipeline?
2:51pm on Tuesday 25th of November, 2025 AEDT
Key Points
Received $1.07 million R&D tax refund from Australian government
Repaid $650,000 loan advanced against FY25 R&D claim, netting $374,000
Funds to support clinical trials, product development, and pipeline initiatives
Advancing HOPE® 1 clinical trials via a special purpose vehicle with $35 million funding
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Zelira Therapeutics (ASX:ZLD)
OPEN ARTICLE